The round was co-led by Cantos and Collaborative Fund, bringing the company's total funding to $11 million. The new capital will support the expansion of MoldCo's virtual clinic and advance its mission to address the widespread yet underdiagnosed health crisis of Mold Toxicity. MoldCo is making expert-led care for mold-related illness more affordable, accessible, and outcomes-driven for patients nationwide.

MoldCo is the first clinician-led digital health platform standardizing mold detox as routine preventative care with affordable on-demand expert care, advanced lab testing, evidence-based treatments, and concierge care support. The company is on a mission to make mold solutions a standard component of full-body health and tackle the widespread, overlooked health crisis of Mold Toxicity. Leading tech VCs, world-renowned physicians, and pioneering researchers support MoldCo's commitment to establishing mold detox as a crucial part of routine preventative care.